Analysts expect Denali Therapeutics Inc. to report revenue of 26.21 M for Q4 26, against a range of 24.51 M to 27.91 M. The most recent reported quarter, Q3 26, came in at 17.78 M, a 31.2% beat against the 13.55 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.60 M | 17.78 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 10.69 M | 1.42 M | 7.43 M | 1.57 M | 3.12 M | 2.60 M | 2.39 M | 14.20 M | 27.91 M | 31.37 M | 35.96 M | 42.48 M | 49.86 M | 60.07 M | 75.88 M | 84.11 M | |||||||||
| Low Estimate | 8.98 M | 1.23 M | 6.35 M | 1.33 M | 2.87 M | 2.40 M | 2.03 M | 12.90 M | 24.51 M | 28.26 M | 32.89 M | 39.63 M | 41.70 M | 53.72 M | 64.25 M | 69.78 M | |||||||||
| Consensus Estimate | 9.84 M | 1.32 M | 6.89 M | 1.45 M | 3.00 M | 2.50 M | 2.21 M | 13.55 M | 26.21 M | 29.81 M | 34.43 M | 41.05 M | 45.78 M | 56.90 M | 70.07 M | 76.94 M |
Analysts expect Denali Therapeutics Inc. to report earnings per share of -0.58 for Q4 26, against a range of -0.62 to -0.54. The most recent reported quarter, Q3 26, came in at 0.37, a 248.0% beat against the -0.25 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.67 | -0.78 | -0.72 | -0.74 | -0.73 | -0.69 | -0.68 | 0.37 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.72 | -0.61 | -0.72 | -0.72 | -0.65 | -0.63 | -0.46 | -0.24 | -0.54 | -0.60 | -0.61 | -0.52 | -0.74 | -0.48 | -0.42 | -0.20 | |||||||||
| Low Estimate | -0.80 | -0.73 | -0.80 | -0.86 | -0.77 | -0.75 | -0.50 | -0.26 | -0.62 | -0.68 | -0.67 | -0.58 | -0.86 | -0.52 | -0.50 | -0.22 | |||||||||
| Consensus Estimate | -0.76 | -0.67 | -0.76 | -0.79 | -0.71 | -0.69 | -0.48 | -0.25 | -0.58 | -0.64 | -0.64 | -0.55 | -0.80 | -0.50 | -0.46 | -0.21 |
Pull Wall Street consensus for Denali Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=DNLI&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "DNLI", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=DNLI&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();